Sponsor Pipeline

Suzhou Biomissile Pharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07698587 A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced… Solid Tumor Not Yet Recruiting
Phase 1
NCT06644300 Study of BM230 in Patients With Advanced Solid Tumors Solid Tumor Recruiting
Get alerts when Suzhou Biomissile Pharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free